Box of Delights Antiques

Cancer Research News

The latest cancer news from the U.S. government's principal agency for cancer research.
  1. As part of the Cancer Grand Challenges program, NCI and Cancer Research UK have announced nine new research challenges to tackle profound problems in cancer research.
  2. A clinical trial led by NCI has resulted in FDA approval of the immunotherapy drug atezolizumab (Tecentriq) to treat advanced alveolar soft part sarcoma.
  3. A statement from the National Cancer Institute by NCI Director Monica M. Bertagnolli, M.D., about her recent diagnosis with early breast cancer.
  4. Overall cancer death rates continued to fall among men, women, children, and adolescents and young adults in every major racial and ethnic group in the United States from 2015 to 2019, according to the latest Annual Report to the Nation on the Status of Cancer.
  5. Monica M. Bertagnolli, M.D., begins her tenure as the 16th director of the National Cancer Institute on October 3, 2022. She previously served as the Richard E. Wilson Professor of Surgery in the field of surgical oncology at Harvard Medical School, a surgeon at Brigham and Women’s Hospital, and a member of the Gastrointestinal Cancer Treatment and Sarcoma Centers at Dana-Farber Cancer Institute.
  6. A new study finds that former smokers who stick to a healthy lifestyle have a lower risk of dying from all causes, including cancer and heart and lung disease, than those who don’t have healthy habits.
  7. A prospective study of half a million tea drinkers in the U.K. suggests potential mortality benefits of drinking black tea may be associated with a lower risk of death.
  8. A study found equivalent amounts of 7 different activities were associated with a lower risk of death from any cause, cardiovascular disease, and cancer.
  9. NCI awards $23 million to academic institutions to establish centers of excellence to conduct research on the role of telehealth in delivering cancer care.
  10. In patients with certain variations in the OAS1 gene, treatment for severe COVID-19 with interferons, a type of protein that can help the body’s immune system fight infections, decreased the viral load of SARS-CoV-2, a new study found.